GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kilitch Drugs (India) Ltd (BOM:524500) » Definitions » Policy Acquisition Expense

Kilitch Drugs (India) (BOM:524500) Policy Acquisition Expense


View and export this data going back to 2001. Start your Free Trial

What is Kilitch Drugs (India) Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Kilitch Drugs (India) (BOM:524500) Business Description

Traded in Other Exchanges
Address
Waman Tukaram Patil Marg, 37/39, Ujagar Industrial Estate, Deonar, Mumbai, MH, IND, 400 088
Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in the manufacture and sales of pharmaceutical products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, HPURE, and others. The company has one reportable segment, which is the development and operations of the Pharmaceutical business. The company has a geographical presence in African countries and several Asian countries.